Synageva BioPharma Corp (NASDAQ:GEVA)

During the Trading Day
98.73 -0.69 / -0.69%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
98.72 -0.0099 / -0.01%
 
Volume: 16.2K
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Baker Bros Advisors Lp
Buy1/07/20151,000,000$94.19$94.2M-4.42%
Baker Bros Advisors Lp
Buy1/07/20151,000,000$94.19$94.2M-4.42%
Patel Sanj K
President & Chief Executive Officer
Sale12/17/201426,960$90.06$2.4M+3.52%
Boess Carsten
Chief Financial Officer & Senior Vice President
Sale10/30/201422,904$80.11$1.8M+24.18%
Goldberg Mark Alan
Sale6/11/201421,597$80.00$1.7M+22.92%
Boess Carsten
Chief Financial Officer & Senior Vice President
Sale2/17/201516,716$100.74$1.7M+0.56%
Boess Carsten
Chief Financial Officer & Senior Vice President
Sale2/17/201514,750$99.97$1.5M+0.56%
Patel Sanj K
President & Chief Executive Officer
Sale12/17/201413,536$87.55$1.2M+3.52%
Boess Carsten
Chief Financial Officer & Senior Vice President
Buy2/17/201529,062$40.74$1.2M+0.56%
Boess Carsten
Chief Financial Officer & Senior Vice President
Sale2/17/20158,989$98.85$888.6K+0.56%
Page of 9

To view my watchlist

Not a member yet?

Sign up now for a free account